Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anca Askanase

Showing results (21-30 of 104) with videos related to

Pageof 11
Sort By:
Lupus Science & Medicine|August 11, 2018
Myocarditis in systemic lupus erythematosus diagnosed by <sup>18</sup>F-fluorodeoxyglucose positron emission tomographyAlexandra Perel-Winkler, Sabahat Bokhari, Thania Perez-Recio, et al.
Annals of the Rheumatic Diseases|April 4, 2020
Laboratory investigation results influence Physician's Global Assessment (PGA) of disease activity in SLECynthia Aranow, Anca Askanase, Shereen Oon, et al.
Arthritis and Rheumatism|February 5, 2010
Cutaneous manifestations of neonatal lupus and risk of subsequent congenital heart blockPeter M Izmirly, Carolina Llanos, Lela A Lee, et al.
Health and Quality of Life Outcomes|March 2, 2017
Development of the Systemic Lupus Erythematosus Steroid Questionnaire (SSQ): a novel patient-reported outcome tool to assess the impact of oral steroid treatmentSusan D Mathias, Pamela Berry, Jane De Vries, et al.
Best Practice & Research. Clinical Rheumatology|August 26, 2023
New and future therapies: Changes in the therapeutic armamentarium for SLEAnca Askanase, Leila Khalili, Wei Tang, et al.
Rheumatology and Therapy|May 24, 2021
The Rise and Fall of Hydroxychloroquine with the COVID-19 Pandemic: Narrative Review of Selected DataWei Tang, Leila Khalili, Jon Giles, et al.
Lupus Science & Medicine|June 1, 2025
Deucravacitinib, an oral, selective, allosteric, tyrosine kinase 2 inhibitor, in patients with active SLE: efficacy on patient-reported outcomes in a phase II randomised trialMarta Mosca, Laurent Arnaud, Anca Askanase, et al.
Lupus Science & Medicine|January 11, 2020
Scoring systemic lupus erythematosus (SLE) disease activity with simple, rapid outcome measuresAikaterini Thanou, Judith A James, Cristina Arriens, et al.
Frontiers in Medicine|June 7, 2022
The Impact of Telemedicine on Rheumatology CareWei Tang, Sean Inzerillo, Julia Weiner, et al.
Research Square|July 7, 2021
Hydroxychloroquine Use Is Not Associated With QTc Length in a Large Cohort of SLE and RA PatientsElizabeth Park, Jon T Giles, Thania Perez-Recio, et al.
Pageof 11

Showing results (21-30 of 104) with videos related to

Sort By:
Pageof 11
Lupus Science & Medicine|August 11, 2018
Myocarditis in systemic lupus erythematosus diagnosed by <sup>18</sup>F-fluorodeoxyglucose positron emission tomographyAlexandra Perel-Winkler, Sabahat Bokhari, Thania Perez-Recio, et al.
Annals of the Rheumatic Diseases|April 4, 2020
Laboratory investigation results influence Physician's Global Assessment (PGA) of disease activity in SLECynthia Aranow, Anca Askanase, Shereen Oon, et al.
Arthritis and Rheumatism|February 5, 2010
Cutaneous manifestations of neonatal lupus and risk of subsequent congenital heart blockPeter M Izmirly, Carolina Llanos, Lela A Lee, et al.
Health and Quality of Life Outcomes|March 2, 2017
Development of the Systemic Lupus Erythematosus Steroid Questionnaire (SSQ): a novel patient-reported outcome tool to assess the impact of oral steroid treatmentSusan D Mathias, Pamela Berry, Jane De Vries, et al.
Best Practice & Research. Clinical Rheumatology|August 26, 2023
New and future therapies: Changes in the therapeutic armamentarium for SLEAnca Askanase, Leila Khalili, Wei Tang, et al.
Rheumatology and Therapy|May 24, 2021
The Rise and Fall of Hydroxychloroquine with the COVID-19 Pandemic: Narrative Review of Selected DataWei Tang, Leila Khalili, Jon Giles, et al.
Lupus Science & Medicine|June 1, 2025
Deucravacitinib, an oral, selective, allosteric, tyrosine kinase 2 inhibitor, in patients with active SLE: efficacy on patient-reported outcomes in a phase II randomised trialMarta Mosca, Laurent Arnaud, Anca Askanase, et al.
Lupus Science & Medicine|January 11, 2020
Scoring systemic lupus erythematosus (SLE) disease activity with simple, rapid outcome measuresAikaterini Thanou, Judith A James, Cristina Arriens, et al.
Frontiers in Medicine|June 7, 2022
The Impact of Telemedicine on Rheumatology CareWei Tang, Sean Inzerillo, Julia Weiner, et al.
Research Square|July 7, 2021
Hydroxychloroquine Use Is Not Associated With QTc Length in a Large Cohort of SLE and RA PatientsElizabeth Park, Jon T Giles, Thania Perez-Recio, et al.
Pageof 11